Match Group: BofA Global Research raises price objective to $41 from $38
MTCH•BofA Global Research raised its price objective for Match Group to $41 from $38.
Related News
Immunocore doses first patient in Phase 1 trial of IMC-S118AI for type 1 diabetes
IMCR•
Rego launches Guardian child-safety platform for mobile gaming industry
RPMT•
Rocket Pharmaceuticals participates in Chardan’s 10th annual healthcare conference
RCKT•
CNX Resources target price cut to $38 from $42 by Mizuho
CNX•
Adlai Nortye partners with Lilly, Merck KGaA on AN4035-cetuximab cancer trial
ANL•